PI therapy evaluated for three months.
D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D010349:Patient Compliance; D012307:Risk Factors
D017320:HIV Protease Inhibitors